13 May 2025 Date | | - Cons. EPS | - EPS |
15 Nov 2024 Date | | - Cons. EPS | - EPS |
16 Aug 2024 Date | | - Cons. EPS | - EPS |
14 Aug 2024 Date | | - Cons. EPS | - EPS |
31 Dec 2016 Date | | - Cons. EPS | - EPS |
13 May 2025 Date | | - Cons. EPS | - EPS |
15 Nov 2024 Date | | - Cons. EPS | - EPS |
16 Aug 2024 Date | | - Cons. EPS | - EPS |
14 Aug 2024 Date | | - Cons. EPS | - EPS |
31 Dec 2016 Date | | - Cons. EPS | - EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Thomas Kidrin CEO | OTC PINK Exchange | 75584Q108 Cusip |
US Country | 1 Employees | - Last Dividend | 22 Oct 2013 Last Split | - IPO Date |